Everence Capital Management Inc Abb Vie Inc. Transaction History

Everence Capital Management Inc

$1.59 Billion
Q3 2024

A detailed history of Everence Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 37,621 shares of ABBV stock, worth $6.61 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

37,621

Previous 37,621 -0.0%

Holding current value

$6.61 Million

Previous $6.12 Million 21.41%

% of portfolio

0.47%

Previous 0.42%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $544,896 - $613,681	-3,960 Reduced 9.52%	37,621 $5.83 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $347,334 - $402,090	-2,600 Reduced 5.88%	41,581 $6.2 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $531,663 - $637,604	3,844 Added 9.53%	44,181 $7.14 Million
Q3 2022 Oct 07, 2022	BUY	$134.21 - $153.93 $300,630 - $344,803	2,240 Added 5.88%	40,337 $5.41 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $759,662 - $965,779	5,520 Added 16.94%	38,097 $5.84 Million
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $995,129 - $1.23 Million	7,540 Added 30.12%	32,577 $5.28 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $1.59 Million - $2.01 Million	-14,780 Reduced 37.12%	25,037 $3.39 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $4,256 - $4,831	40 Added 0.1%	39,817 $4.3 Million
Q4 2020 Feb 01, 2021	SELL	$80.49 - $108.67 $258,372 - $348,830	-3,210 Reduced 7.47%	39,777 $4.26 Million
Q3 2020 Feb 01, 2021	BUY	$85.91 - $100.83 $233,675 - $274,257	2,720 Added 6.75%	42,987 $3.77 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $451,078 - $603,610	6,148 Added 18.02%	40,267 $3.73 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $164,528 - $205,860	-2,281 Reduced 6.27%	34,119 $3.02 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $481,507 - $566,711	-6,242 Reduced 14.64%	36,400 $2.93 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $238,946 - $262,024	2,668 Added 6.67%	42,642 $4.12 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $2.79 Million - $3.57 Million	39,974	39,974 $3.55 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Abb Vie Inc. Transaction History